Humana Inc. ($HUM) Stock Forecast: Down 5.1% Today

What is Humana Inc.?

Humana (HUM) is a healthcare insurer that has recently experienced a bearish movement in the stock market.

Why is Humana Inc. going down?

HUM stock is down 5.1% on Dec 16, 2025 18:10

• Humana's stock dropped after announcing the retirement of its current insurance president and the appointment of a former Amazon executive to the role. This leadership change may have caused uncertainty among investors, leading to the bearish market movement.
• The reaffirmation of annual guidance by Humana, despite falling short of consensus estimates for earnings per share, could have further contributed to the negative sentiment among investors.
• The lack of commentary on the 2026 open-enrollment period may have also added to investor concerns about the company's future profitability, prompting the bearish trend in the stock price.

HUM Price Chart

HUM Technical Analysis

HUM News

Humana Names Former Amazon Executive Next Insurance President. The Stock Drops.

Humana's stock fell following the announcement that a former Amazon executive would be the next insurance president, taking over from a retiring incumbent. The healthcare insurer also reiterated its guidance for the current year. Humana's shares have risen 15% over the past 12 months despite this recent dip.

https://www.barrons.com/articles/humana-stock-price-amazon-president-earnings-guidance-8c3277ed?gaa_at=eafs&gaa_n=AWEtsqfEhXUEANsK4plWHvCVi636nDxDYeB2cVzdk2fwTtEDAdVMyHFPOT-f&gaa_ts=69419503&gaa_sig=rz2sXW6gUvQBVJh8bonl18pOw7oLctpJJIoReOK5ePnfANCSkUfqGZeNyYmYlZ9WfECaI1itUFr6UnbXOB2k4Q%3D%3D

Humana taps Amazon executive to head insurance unit as veteran retires

Humana announced that George Renaudin will retire as president of its insurance segment next year, with Amazon healthcare executive Aaron Martin named as his successor. Martin, who previously oversaw strategic partnerships and telehealth programs at Amazon, will join Humana in January, initially as president of Medicare Advantage before taking over the insurance segment role. The announcement comes as Humana reaffirmed its annual adjusted profit forecast, but analysts noted investor concern due to the lack of commentary on the 2026 open-enrollment period.

https://www.reuters.com/legal/litigation/humana-taps-amazon-executive-head-insurance-unit-veteran-retires-2025-12-16/

Humana Stock Slips After Naming Former Amazon Executive as Next Insurance President

Humana's stock fell following the announcement of its current insurance president's retirement and the reiteration of its annual guidance. The company named a former Amazon executive as the new president of its insurance division. This news comes as Humana shares have seen a 15% increase over the past year.

https://www.barrons.com/articles/humana-stock-price-insurance-medicare-8c3277ed?gaa_at=eafs&gaa_n=AWEtsqdIS6ASMe_hNuaQhKBgSMMp13i5QlIU8shElQHbv6-ohw9zcgn_u6aI&gaa_ts=694178df&gaa_sig=Zg9Vt9uWy6cU8g8MwkuNL_OiFmiMoERDslhITYwX_bYv5JUPFpb7odbwgh9Fa4SYXDzNM4h-zFVEfwge0iPYWw%3D%3D

Humana drops as reaffirmed EPS guidance falls short of consensus

Humana's stock fell after the company reaffirmed its prior 2025 earnings per share (EPS) guidance. This guidance, while reiterated, came in below the consensus estimates from analysts, raising investor concerns about future profitability. The market reacted negatively, leading to a drop in the company's share price.

https://www.msn.com/en-us/money/savingandinvesting/humana-drops-as-reaffirmed-eps-guidance-falls-short-of-consensus/ar-AA1SsmFb?ocid=finance-verthp-feeds

Tyler Technologies director Carter sells $229k in stock By Investing.com

Glenn A. Carter, a director at Tyler Technologies (NYSE:TYL), sold 500 shares of common stock for $229,364 and exercised options to acquire 500 shares for $73,460 on December 12, 2025. The company recently acquired Edu.Link Incorporated and CloudGavel, and received varied analyst ratings with TD Cowen initiating a Buy, Truist Securities maintaining a Buy with a lowered price target, and DA Davidson reducing its price target while maintaining a Neutral rating.

https://ng.investing.com/news/insider-trading-news/tyler-technologies-director-carter-sells-229k-in-stock-93CH-2255137

Trending Today

Humana Inc. Price History

02.09.2025 - HUM Stock was down 0.2%

• Humana's stock experienced a bearish movement today, possibly due to:
• Pressure from high benefit ratios and costs impacting the company's profitability.
• Investor concerns raised by an investigation initiated by Bragar Eagel & Squire, P.C., leading to a loss in investor confidence.
• Despite benefiting from rising premiums and Medicare growth, these positive factors might have been overshadowed by the negative aspects, contributing to the bearish trend.
• The comparison with Akero Therapeutics, Inc. might have also influenced investor sentiment, especially if Akero Therapeutics has been outperforming Humana in the sector, leading to a shift in investment focus away from Humana.

03.11.2025 - HUM Stock was up 5.7%

• The collaboration between Humana and Epic to automate insurance verification processes has likely boosted investor confidence in the company's operational efficiency and potential cost savings, contributing to the bullish movement.
• Panagora Asset Management Inc.'s significant increase in stake in Humana indicates growing investor interest and confidence in the company's future performance, especially after beating Q3 earnings estimates.
• Despite the positive momentum, the investigation into potential stockholder claims and allegations of illegal kickbacks may have initially caused some uncertainty and a slight decline in the stock price, but the overall market sentiment remains positive given the company's strong financial performance and strategic initiatives.

03.11.2025 - HUM Stock was up 6.4%

• Recent positive investor sentiment and increased stake by Panagora Asset Management Inc. have contributed to Humana's bullish movement, following a strong Q3 earnings performance.
• The collaboration to automate insurance verification processes with Epic has improved operational efficiency and demonstrated a commitment to enhancing patient outcomes through technology.
• Speculation surrounding CVS Health's forthcoming investor day and a positive industry outlook have also likely influenced the uptrend in Humana's stock.
• Overall, strategic initiatives, robust financial performance, and partnerships within the industry are driving investor confidence and boosting the stock's momentum.

26.10.2025 - HUM Stock was up 5.2%

• Humana's bullish movement today could be attributed to the national coverage agreement signed with Plus Therapeutics for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer. This partnership and expansion of services could have positively impacted investor sentiment towards Humana's growth prospects in the healthcare sector.
• UnitedHealth's push towards a hybrid care model, combining digital tools with in-person care, may have also influenced the bullish trend in the healthcare industry, including companies like Humana. This strategic approach to healthcare delivery could signal potential industry-wide shifts and opportunities for growth.
• The market's positive reaction to Humana's strategic partnerships and focus on innovative healthcare solutions indicates investor confidence in the company's ability to adapt to evolving market trends and drive value for its stakeholders.

10.09.2025 - HUM Stock was down 6.7%

• The bearish movement in Humana's stock today could be attributed to an ongoing investigation, causing uncertainty among investors.
• The news of a competitor expanding its initiative to reduce hospital readmissions may have negatively impacted Humana's stock, signaling increased competition in the healthcare sector.
• Despite a recent jump in Humana's share price, the lack of promising trends in earnings estimate revisions may have contributed to today's bearish movement.
• Investors might be reacting to the overall sentiment in the healthcare industry, leading to a sell-off in Humana's stock amidst uncertainties about the company's future prospects.

16.11.2025 - HUM Stock was down 5.1%

• Humana's stock dropped after announcing the retirement of its current insurance president and the appointment of a former Amazon executive to the role. This leadership change may have caused uncertainty among investors, leading to the bearish market movement.
• The reaffirmation of annual guidance by Humana, despite falling short of consensus estimates for earnings per share, could have further contributed to the negative sentiment among investors.
• The lack of commentary on the 2026 open-enrollment period may have also added to investor concerns about the company's future profitability, prompting the bearish trend in the stock price.

11.11.2025 - HUM Stock was up 5.4%

• Institutional investors, including State Street Corp, are increasing their holdings in Humana, indicating growing confidence in the company's future prospects, which is contributing to the bullish movement in the stock.
• CVS Health recently announced a strategic plan that emphasizes technology-driven growth and higher-margin segments, positively impacting the healthcare sector and potentially boosting investor sentiment towards companies like Humana.
• Humana's dedication to community impact through funding non-profit organizations in Oklahoma is in alignment with its values and enhances its reputation, attracting socially responsible investors.
• California Public Employees Retirement System and Federated Hermes Inc. have increased their stake in Humana, reinforcing the positive outlook on the company. Analysts maintain a "Hold" rating but with a target price indicating potential growth ahead.

01.09.2025 - HUM Stock was down 4.6%

• The bearish movement in Humana's stock today could be attributed to the unusual options activity indicating that high-rolling investors have taken a bearish stance on the company.
• The investigation by Bragar Eagel & Squire, P.C. on behalf of long-term stockholders might have raised concerns among investors, leading to a sell-off in the stock.
• The comparison with Akero Therapeutics and other medical peers in the sector may have highlighted relative underperformance, further dampening investor sentiment towards Humana.
• Overall, the combination of negative news flow and bearish market sentiment from high-profile investors likely contributed to the significant downward movement in Humana's stock price today.

11.11.2025 - HUM Stock was up 5.1%

• The bullish movement in Humana Inc. ($HUM) stock today can be attributed to the increased holdings by institutional investors like State Street Corp and California Public Employees Retirement System, indicating confidence in the company's growth prospects and financial performance.
• The announcement of Humana Healthy Horizons in Oklahoma funding six nonprofits with $295,500 showcases the company's commitment to addressing critical health-related social needs, which may have positively influenced investor sentiment.
• Analysts maintaining a "Hold" rating on Humana with a consensus target price of $296.84 suggests a stable outlook for the stock, supported by the company's strategic initiatives and dividend payouts.
• Overall, the positive market movement of Humana Inc. ($HUM) today reflects investor optimism fueled by institutional investments, community impact initiatives, and steady growth projections in the healthcare sector.

05.10.2025 - HUM Stock was down 7.3%

• Despite surpassing earnings and revenue expectations in the third quarter, Humana's stock faced significant downward pressure.
• Concerns regarding future growth potential may have influenced the market's negative response, despite the company outperforming financially.
• Investors could be considering factors beyond quarterly results, such as future guidance and industry trends, contributing to the stock's bearish performance.
• The presence of a hammer chart pattern and positive trend in earnings estimates, as highlighted elsewhere, might not have been adequate to counter the overall market sentiment impacting Humana's stock.

05.10.2025 - HUM Stock was down 7.3%

• Despite surpassing Q3 earnings expectations and showing robust premium growth, Humana stock underwent a bearish trend.
• The negative market response may be attributed to increased expenses and declining memberships affecting the company’s performance, notwithstanding the positive earnings and revenue outcomes.
• Shareholders may have expressed dissatisfaction with the lower quarterly earnings per share in comparison to the previous year, falling short of analysts' projections.
• The fluctuating U.S. stock futures market and attention directed towards other companies such as McDonald's might have also influenced the downward movement in Humana stock today.

05.10.2025 - HUM Stock was down 8.7%

• Despite beating Q3 earnings and revenue estimates, Humana's stock experienced a bearish movement, possibly due to analysts revising expectations downwards for the quarter.
• The hammer chart pattern indicating potential support for the stock might not have been enough to offset concerns about the decrease in earnings per share compared to the previous year.
• The focus on rising premiums and service revenues to boost Q3 earnings may not have fully convinced investors, leading to a sell-off in the stock.
• Overall, the mixed market sentiment and cautious outlook from analysts could have contributed to the bearish movement in Humana's stock today.